179 related articles for article (PubMed ID: 20675120)
21. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
22. Guidelines to assure quality in breast cancer surgery.
Rutgers EJ
Eur J Surg Oncol; 2005 Aug; 31(6):568-76. PubMed ID: 16023942
[TBL] [Abstract][Full Text] [Related]
23. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
National Institutes of Health Consensus Development Panel
J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
[TBL] [Abstract][Full Text] [Related]
24. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?
Malin JL; Schneider EC; Epstein AM; Adams J; Emanuel EJ; Kahn KL
J Clin Oncol; 2006 Feb; 24(4):626-34. PubMed ID: 16401682
[TBL] [Abstract][Full Text] [Related]
25. [The German Guideline Clearinghouse on Breast Cancer: the need for frequent updating of breast cancer guidelines requires effective guideline updating procedures].
Weingart O; Sonntag D; Trapp H; Bartsch HH; Baumeister RG; Goerke K; Giersiepen K; Hindenburg HJ; Ming K; Schulz-Wendtland R; Störkel S; Kober T; Thole H; Kirchner H; Ollenschläger G;
Z Arztl Fortbild Qualitatssich; 2004 Aug; 98(5):403-11. PubMed ID: 15487388
[TBL] [Abstract][Full Text] [Related]
26. Adjuvant therapy for breast cancer.
NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
[TBL] [Abstract][Full Text] [Related]
27. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer. Canadian Association of Radiation Oncologists.
CMAJ; 1998 Feb; 158 Suppl 3():S3-8. PubMed ID: 9484272
[TBL] [Abstract][Full Text] [Related]
28. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
29. [Efficiency versus quality in the NHS, in Portugal: methodologies for evaluation].
Giraldes Mdo R
Acta Med Port; 2008; 21(5):397-410. PubMed ID: 19187682
[TBL] [Abstract][Full Text] [Related]
30. [Standards, Options and Recommendations for non metastatic breast cancer patients].
Mauriac L
Bull Cancer; 2002 Feb; 89(2):207-24. PubMed ID: 11888860
[TBL] [Abstract][Full Text] [Related]
31. Preventive health care, 1999 update: 3. Follow-up after breast cancer. Canadian Task Force on Preventive Health Care.
Temple LK; Wang EE; McLeod RS
CMAJ; 1999 Oct; 161(8):1001-8. PubMed ID: 10551200
[TBL] [Abstract][Full Text] [Related]
32. The quality of early-stage breast cancer treatment: what can we do to improve?
Bickell NA; Mendez J; Guth AA
Surg Oncol Clin N Am; 2005 Jan; 14(1):103-17, vi. PubMed ID: 15542002
[TBL] [Abstract][Full Text] [Related]
33. Clinical quality indicators of venous leg ulcers: development, feasibility, and reliability.
Kjaer ML; Mainz J; Soernsen LT; Karlsmark T; Gottrup F
Ostomy Wound Manage; 2005 May; 51(5):64-6, 68-72, 74. PubMed ID: 16014986
[TBL] [Abstract][Full Text] [Related]
34. Evaluating the organization and delivery of breast cancer services: use of performance measures to identify knowledge gaps.
Gagliardi A; Wright FC; Quan ML; McCready D
Breast Cancer Res Treat; 2007 Jun; 103(2):131-48. PubMed ID: 17077995
[TBL] [Abstract][Full Text] [Related]
35. [Standards, Options and Recommendations (SOR): clinical practice guidelines for diagnosis, treatment and follow-up of cutaneous melanoma. Fédération Nationale des Centres de Lutte Contre le Cancer].
Négrier S; Fervers B; Bailly C; Beckendorf V; Cupissol D; Doré JF; Dorval T; Garbay JR; Vilmer C
Bull Cancer; 2000 Feb; 87(2):173-82. PubMed ID: 10705288
[TBL] [Abstract][Full Text] [Related]
36. Background to Eusoma guidelines and statements.
Greco M; Marotti L;
Eur J Cancer; 2006 Sep; 42(14):2200-4. PubMed ID: 16905307
[TBL] [Abstract][Full Text] [Related]
37. National quality validation programs for breast centers.
Kaufman CS
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1357-62. PubMed ID: 17944561
[TBL] [Abstract][Full Text] [Related]
38. Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.
Gralow JR; Burstein HJ; Wood W; Hortobagyi GN; Gianni L; von Minckwitz G; Buzdar AU; Smith IE; Symmans WF; Singh B; Winer EP
J Clin Oncol; 2008 Feb; 26(5):814-9. PubMed ID: 18258991
[TBL] [Abstract][Full Text] [Related]
39. Breast cancer: relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors.
Schultz PN; Klein MJ; Beck ML; Stava C; Sellin RV
J Clin Nurs; 2005 Feb; 14(2):204-11. PubMed ID: 15669929
[TBL] [Abstract][Full Text] [Related]
40. CCORT/CCS quality indicators for congestive heart failure care.
Lee DS; Tran C; Flintoft V; Grant FC; Liu PP; Tu JV;
Can J Cardiol; 2003 Mar; 19(4):357-64. PubMed ID: 12704479
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
